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Abstract: Autism spectrum disorder (ASD) is a group of
heterogeneous neurodevelopmental disorders character-
ized by impairments activities without efficient pharma-
cological therapies in social interaction, speech and
stereotypic patterns. Clinical studies have shown the effi-
cacy of acupuncture as an alternative therapy for autism.
The effectiveness of acupuncture as an alternative treat-
ment for autism has been demonstrated through clinical
trials. However, the molecular mechanisms that underlie
these effects remain unclear. Due to its profound pro-
social, anxiolytic, stress management effects, and its
potential use for the treatment of psychiatric disorders
associated with altered socioemotional competence, oxy-
tocin (OT) released from the hypothalamus has attracted
considerable interest. In the past decade, a number of
clinical and animal studies have shown that OT administra-
tion effectively reduces core symptoms of ASD, especially
social behavior deficits. Recently, the endocannabinoid
system has emerged as a promising target for the treatment
of autism. OTwas found to facilitate the endocannabinoid-
mediated social reward processes in the nucleus accum-
bens of the mouse brain. Furthermore, serotonin and
dopamine are involved in the reward response mediated
by OT. In view of these findings, we conclude that acu-
puncture may produce therapeutic effects on autism by
triggering the hypothalamic oxytocin system,which in turn
activates the release of neurotransmitters such as endocan-
nabinoids, dopamine and serotonin. This would be a valu-
able guide for further research on the mechanism of treat-
ment of autism with acupuncture.
Keywords: autism spectrum disorder, oxytocin, endocan-
nabinoid, serotonin, dopamine, nucleus accumbens, ven-
tral tegmental area
Autism spectrum disorder (ASD) is a developmental dis-
ability, typically manifested as difficulties in social inter-
action, repetitive behaviors and deficiency in language
communication, which seriously affects the quality of
life of patients. So far, there are no effective medicines
for the treatment of ASD. However, studies indicate that
early intervention can improve children’s development.
The cause of ASD has not been fully determined, but
cumulative evidence has shown that the onset of ASD is
the result of multifactor interactions, including gene
mutation, environmental contamination, and abnormal
development of central nervous system (CNS) [1,2]. In
terms of the nervous system, the pathogenesis of ASD is
closely associated with damaged neurotransmitter sys-
tems in the nervous system, such as serotonin (5-HT),
norepinephrine, dopamine, and pineal–hypothalamic–
pituitary–adrenal axis dysfunction, and related neuro-
peptides and hormones [3–5].
Peñagarikano et al. demonstrated that oxytocin (OT)
significantly improves social behavior in a mouse model
of autism, and that this effect can be sustained over a
longer period of time if treated early [6]. Recently, a
research group from Hamamatsu Medical University in
Japan announced that they have shown a tendency to
improve symptoms in people with ASD after injecting
with OT (a trial of TTA-121 on autism spectrum disorder).
It is known that OT is mainly produced by the giant cells
in the supraoptic nucleus (SON) and paraventricular
nucleus (PVN) of the hypothalamus, then transported
through the nerve fibers of the hypothalamic pituitary
axis to the posterior pituitary gland, and finally released
into the blood, acting on various organs throughout the
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body, and finally exerts its important biological functions
[7]. In women, OT can trigger uterine contractions in
childbirth, stimulate milk secretion, and create contact
between the mother and the child through affection. In
addition, OT can also reduce the levels of corticosterone
and other stress hormones in the body, and lower the
blood pressure [8]. Overall, OT is critical for enhancing
social behavior deficits associated with ASD, establishing
relationships and engaging in social interaction, the
abnormal concentration, or functions of OT is closely
linked to autism pathogenesis.
1 OT deficiency is associated with
social deficits in autism
OT is a highly conserved 9-peptide that is synthesized by
neuronal cells in the PVN and SON of the hypothalamus
and then released into the blood through the axonal
endings of the posterior lobe of the neurohypophysis.
Endogenous OT receptors (OTRs) have a broad distribu-
tion in the brain, particularly in the entire limbic system.
The central neurotransmitter-like action of OT has been
predominantly shown to modulate cognitive effects, reg-
ulating the development and maintenance of complex
social and bonding behaviors.
Accumulative evidence indicates that OT plays a
putative role in social communication, and the lack or
under-use of OT may be connected to disorders related
to social communication. Decreased OT and its receptor
may lead to low social activity and autism-like behaviors,
and this shift in the OT system is commonly observed in
patients with ASD. In 1998, Modahl et al. first reported
that OT deficiency in autistic children could be the cause
of social disorders. They found that plasma OT levels
were significantly lower in autistic children than in
normal children of the same age, and the decrease in
OT level was significantly linked to the degree of social
communication impairment in autistic children. They
also found that plasma OT levels did not increase with
age in autistic children, as normal children did [9]. In
addition, social deficits and reduced OT immunostaining
have been reported in several models of autism, such as
the developmental hyperserotonemia (DHS) model [10],
the Cntnap2 mouse model [6], the prenatal valproic acid
(VPA) rats model [11], and Shank3b−/− mutant mice model
[12]. In the Cntnap2 and VPA model, exogenous OT admin-
istration in early life was sufficient to rescue decreased OT
immunoreactivity as well as social functioning, indicating
that a crucial developmental time window could be required
for optimal treatment [6,11]. These results indicate that a key
cause to the development of autism could be the reduction
or dysfunction of OT.
During long labors, the desensitization of OTR with
long infusion periods of Pitocin and high infusion rates
may be followed by down-regulation of OTR, which may
be a cause that contributes to autism in offspring [13–15].
Furthermore, studies in OT [16] or OTR [17] gene knockout
mice have shown abnormal social behaviors and ASD-like
traits related social memory deficits. Animal experiments
and clinical studies also have shown that intranasal or per-
ipheral OT injection can obviously promote social interac-
tion [6,18], but the therapeutic mechanism remains unclear.
The possible mechanism could be linked to the excitatory–
inhibitory shift of OT-mediated neuroprotective GABA
during the perinatal period [19]. In ASD rodent models,
the early birth GABA excitatory–inhibitory shift is disrupted,
leading to greater excitatory GABA transmission and the
followed autism-like behavior. The number of OT-immuno-
responsive (OT-ir) cells in the SON of neonatal VPA autism
rats was significantly lower than that of the control group.
Early postnatal OT treatment (subcutaneous injection for
7 days from 24 h after birth) has a long-term therapeutic
effect and can relieve social disorders and repetitive beha-
vior before puberty. These behavioral changes are accompa-
nied by an increase in the number of OT-ir cells [11].
2 OT deficiency is attributed to the
stereotyped repetitive behaviors
in autism
Another main characteristic of autism is repetitive and
stereotypic behavior, which often occurs in other mental
and psychological disorders, such as Angelman’s syn-
drome, Tourette’s syndrome, and obsessive-compulsive
disorder. The OT system has been linked to the regulation
of repetitive behavior in both animal models and human
patients. For example, the OTR knockout mice showed
high frequency of repetitive stereotyped behavior, such
as increased self-grooming [20] and marble burying [21].
After OT treatment, these repetitive and stereotyped beha-
viors were substantially reduced [21,22].
In children with ASD, the plasma OT level was con-
siderably lower than that in normal children. The corre-
lation between OT and the repetitive stereotyped behaviors
was found to be significant. Lower OT levels are often
accompanied by more severe symptoms of stereotyped
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behavior in ASD children [23]. Furthermore, clinical trials
have shown that OT administration effectively mitigated
repetitive stereotyped behavior and improved comprehen-
sion of affective speech [24,25].
3 Acupuncture can cause prosocial
effects of oxytocin
Although human intranasal OT studies illustrate a new
hope for ASD, it should be noted that these studies had
small sample sizes and some research identified rela-
tively poor replicability, suggesting that intranasal OT
studies are generally low statistical power [26]. Exo-
genous intranasal OT administration may also cause
side effects such as nasal irritation, light headedness,
drowsiness, and/or headache [27]. Bypassing the blood-
brain barrier during exogenous pharmacological inter-
vention remains a problem that needs to be tackled for
a long time. Some research has turned to promoting
endogenous oxytocin signaling [28].
Acupuncture is an important part of traditional Chinese
medicine, which has been widely used as an alternative
therapy for a variety of diseases. Acupuncture at specific
acupoints regulates the neuro–immuno–endocrine network
[29]. The hypothalamus is the key element of the hypotha-
lamic–pituitary–adrenal cortex (HPA) axis, which perceives
a multitude of signaling including stressful stimulations
and acupuncture signals. It has been confirmed that acu-
puncture at specific acupoints specifically activates stress
reaction neurons (SRNs) in PVN and influences the CNS
through the HPA axis [30]. Several lines of evidence indi-
cate that acupuncture treatment can improve the social and
emotional responses of autistic patients characterized by
impaired social behavior [31–34]. Studies have shown that
acupuncture or electroacupuncture (EA) stimulation with
unique frequency can promote the release of specific neuro-
chemicals in the CNS and produce noticeable physiological
effects [35]. For example, rats exposed to 30min of 2 Hz EA
treatment showed significant increase of the OT levels in
plasma and in the cerebrospinal fluid (CSF) [36]. In addi-
tion, 10–20Hz EA treatment can upregulate OT level in the
SON of the hypothalamus in rats [37].
The damage of central OT systemwas reported for the
first time in VPA autism rat model [11]. Compared with
the control group, the OT mRNA level and peptide con-
centration in hypothalamus of the male and female VPA
rats were much lower than that of the control animals,
and the level of OT peptide in CSF remarkably decreased.
Zhang et al. found that EA stimulation (2/15 Hz dense-
disperse pulses wave) led to a selective increase in the
expression of OT and arginine–vasopressin (AVP) in the
hypothalamus. Furthermore, 2/15 Hz EA treatment increased
the social interaction time in low socially interacting (LSI)
rats. In addition, single-sequence EA stimulation can up-
regulate the mRNA levels of hypothalamic OT and AVP.
Similarly, repeated sequence EA stimulation can up-regulate
the levels of OT andAVPmRNA and promote protein expres-
sion in SON, accompanied by a significant increase in serum
AVP and enhanced sociability. The social behavior of rats
was positively correlated with the mRNA levels of OT and
AVP in the hypothalamus, suggesting that the socialization-
promoting response observed after EA may be at least par-
tially mediated by the upregulation of OT and AVP in the
brain [38].
Based on the above studies, acupuncture may ame-
liorate the behavioral symptoms of autism by up-regu-
lating the level of OT and AVP in the hypothalamus.
Transcutaneous electrical acupoint stimulation (TEAS)
is a non-invasive acupuncture-like technique, which is
easy to apply in young children. The physiological effects
of TEAS are similar to that of EA on analgesia [39] and
other diseases [40]. Acupuncture intervention at an early
age or during developmental critical periods may be ben-
eficial to the facilitation of AIDRR (Activate, Integrate,
Discriminate, Respond, Reward) neural loop [41]. A func-
tional magnetic resonance imaging investigation demon-
strated that acupuncture at “Fengchi” (GB 20) specifically
targeting the cerebello–thalamo–cortical (CTC) circuit to
alleviate the PD tremor [42]. Acupuncture may also alle-
viate autism symptoms through activating endogenous
OT signals by stimulating specific neural circuits in the
brain rather than affecting the entire brain with pharma-
cotherapy [28]. The clinical studies from Beijing Wucailu
Autism Rehabilitation Center provide solid evidences that
children in the TEAS group had better scores in Childhood
Autism Rating Scale (CARS) as well as in the Autism Beha-
vior Checklist (ABC) compared with the ASD children who
only received rehabilitation training, and the levels of AVP
and OT in plasma were significantly higher than those in
the control group [43].
4 Oxytocin stimulates anandamide
release in the nucleus
accumbens
The endocannabinoids system (ECS) is an essential
neuro-modulatory system that involves the regulation
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of neurotransmission and synaptic plasticity in a broad
range of social emotional responses and cognitive func-
tions. ECS consists of two primary cannabinoid receptors
(CB1 and CB2), their endogenous lipid ligands, endocan-
nabinoids, including N-arachidonoylethanolamine (ana-
ndamide, AEA), 2-arachidonoylglycerol (2-AG)), and their
biosynthesis- and degradation-related enzymes. ECS has
been shown to be implicated in social behavior regula-
tion [44]. Recently, dysregulation of endocannabinoid sig-
naling has been confirmed in both genetic and epigenetic
models of ASD [45,46]. Pharmacological blockade of fatty
acid amide hydrolase (FAAH), the main degrading enzyme
of AEA, rescued ASD behavioral defects and comorbidities
in different preclinical models [47]. Cannabidiol (CBD), the
major non-psychoactive phytocannabinoid in cannabis is
effective in improving the symptoms of ASD [48].
With respect to OT and ECS, rodent studies have sug-
gested a complex relationship between CB1 and OT, par-
ticularly in social behavior. Chemogenetic activation of
PVN OT neurons increased nucleus accumbens (NAc)
endocannabinoid AEA content in an OTR-dependent
manner, suggesting that the artificial activation of PVN
OT neurons induced local AEA release [49]. These studies
indicate that deficits in the AEA signaling mechanism
driven by OT may contribute to social impairment in
ASD and a correction of such deficits may provide a
novel strategy for the treatment of ASD-related social
impairments.
Our previous work and other animal studies have
consistently shown that 2 Hz EA can increase endogenous
cannabinoid AEA levels in both the peripheral skin tis-
sues and the central nervous system [50,51]. These find-
ings support the hypothesis that acupuncture can, on the
one hand, directly up-regulate the signal of endogenous
cannabinoid system to promote social interaction, and,
on the other hand, by regulating OT signals to treat the
behavioral symptoms of autism, it can also indirectly up-
regulate the level of endogenous cannabinoid.
5 Serotonin and dopamine are
involved in acupuncture-
mediated oxytocin rewarding
Both clinical and preclinical studies have confirmed the
role of serotonin in the pathophysiology of autism. In
addition, the imbalance of dopamine (DA) in specific
brain regions may contribute autistic behaviors. These
studies suggested that ASD could be closely connected
to serotoninergic and dopaminergic systems [52,53].
Animal studies have shown that OT acts on serotoni-
nergic and dopaminergic neurons and participates in
many forms of social behaviors [54]. Therefore, it is
conceivable that the beneficial characteristics of social
Figure 1: A hypothetical model of the possible mechanism of acupuncture for the treatment of autism. Acupuncture or electric acupuncture
(EA) at specific acupoints with a certain frequency alleviates impaired social behaviors by directly up-regulating the oxytocin level in the
hypothalamus or implicitly activating the endogenous cannabinoid, 5-HT, or DA signal pathway. OT: oxytocin; OTR: oxytocin receptor; AEA:
anandamide; NAc: nucleus accumbens; VTA: Ventral tegmental area.
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interaction can be mediated by the coordinated activity of
OT and serotonin (5-HT) in NAc. Walsh et al. have shown
that optogenetic stimulating 5-HT release in the NAc or
pharmacological activation of NAc 5-HT1b receptors res-
cues social deficits in 16p11.2 deletion autism mouse
model [55]. In addition, autistic children have shown
defects in the mesocorticolimbic dopaminergic signaling
pathway, such as decreased prefrontal cortex dopamine
release [56] and reduced NAc neural response [57]. PVN
OT neurons project directly to the ventral tegmental area
(VTA) and activate OTRs to regulate the social behavior.
Consistent with OT-driven increased activity of VTA DA
neurons, VTA OT administration increases DA release as
well as sociability, thereby increasing DA release in the
NAc, and activating PVN-VTA circuit enhances prosocial
behavior in murine models [58]. It is known that EA at
different frequencies can promote the release of different
neurotransmitters [35]. Acupuncture at the specific acu-
point (“Shenshu” (BL23)) increased NAc 5-HT release in
rats [59]. Whereas 2 Hz EA in another region (“Zusanli”
(ST 36)) was able to elevate both DA and 5-HT level in the
rat hypothalamus [60].
These findings indicate that acupuncture may also
promote social interaction by directly regulating the 5-
HT or DA system, or by facilitating the release of neuro-
transmitters in the brain’s rewarding region through the
oxytocinergic systems.
6 Conclusion
In reviewing previous and current acupuncture and ASD
studies, we speculate that acupuncture may improve the
behavioral symptoms of autism by directly up-regulating
the level of OT in the hypothalamus and perhaps further
promoting the synthesis, recruitment, and release of
endogenous cannabinoid AEA, 5-HT, DA by increasing
the level of OT in the key regions of the regulatory reward
system in the brain (Figure 1). Future studies will uncover
the underlying mechanisms of the treatment effects of
acupuncture on ASD through applying neural tracing,
brain mapping, calcium imaging, optogenetics, chemo-
genetics, and in vivo multichannel recording techniques.
Human studies rely primarily on peripheral plasma OT
measurement, but the correlation between central and
peripheral OT has not been understood. In autistic chil-
dren, plasma OT levels are lower than in age-matched
controls, but many aspects of the metabolic pathways
of OT are still poorly understood. It is also necessary to
study whether there is insufficient use of OT in autistic
children in the future. Currently, most studies are still in
the preclinical stage on the relationship between ASD
and OT. A thorough investigation of how acupuncture
activates endogenous OT signals through affecting spe-
cific neural circuits to treat autism will be a critical step in
bridging the translational gap between animal models
and human therapeutics.
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